FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Publications
  • Links
  • Events
    • Guest lectures
    • Retreats
    • Symposium
  • News
✕

DFG research unit FOR 2240 in the press: Special issue in Klinische Monatsblätter für Augenheilkunde

In May 2017, the journal Klinische Monatsblätter Augenheilkunde (engl. Clinical Monthly for Ophthalmology, founded in 1863) devoted a special issue to the Research Unit FOR 2240, whose main seat is in the Department of Ophthalmology at the University of Cologne.

The Research Unit FOR 2240 “Angiogenesis, lymphangiogenesis and cellular immunity in inflammatory diseases of the eye” is a stand-alone in the medical specialty of ophthalmology: it is the only  research unit in ophthalmology to be funded by the German Research Foundation (DFG). The DFG Research Unit FOR 2240 currently has six basic projects carried out at three locations (Cologne, Muenster and Erlangen-Nuremberg) and two Cologne-based, overarching central projects with supportive aims.

Here is a pdf of the German-language overview of the research unit, which the Stuttgart-based Thieme Publishers put out in the May 2017 special issue of Klinische Monatsblätter Augenheilkunde, along with four further contributions by the FOR 2240 projects.

Related posts

July 28, 2023

Modern laboratory – microscope donated


Read more
January 7, 2023

Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface


Read more
December 15, 2022

Leonhard Klein-Preis for Prof. Matthaei


Read more

News

  • International guest from Japan
  • Academia Ophthalmologica Internationalis: Prof. Cursiefen new member
  • National top ranking for ophthalmology
  • Funding for glaucoma stent study
  • The aging eye

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Claudia Bock
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
claudia.bock@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck